Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3672 Impact of everolimus starting dose on antiproliferative efficacy in patients with neuroendocrine tumors – Experiences from a tertiary referral center

Introduction: Everolimus is approved at a full dose of 10 mg daily for the treatment of advanced neuroendocrine tumors (NETs) but associated with relevant toxicities. Hence dose reductions are a frequent event in clinical practice.

Conference:

Presenting Author: Kiesewetter B

Authors: Kiesewetter B, Melhorn P, Macheiner S, Wolff L, Kretschmer-Chott E,

Keywords: everolimus, dose reduction, advanced NET, systemic therapy, medical oncology,